Healthcare providers express cash flow concerns under new 340B rebate model
Editor's Note Healthcare providers could experience significant cash flow and operational changes under a new voluntary pilot program that fundamentally alters how the nation's second-largest drug payment program operates, according to an August 11 article in Modern Healthcare. As detailed in the article, The Health Resources and Services Administration announced…
FDA orders opioid label changes to highlight long-term risks
Editor's Note The US Food and Drug Administration (FDA) is requiring safety labeling changes for all opioid pain medications to better emphasize and explain the risks associated with long-term use, according to a July 31 announcement. These changes follow a May advisory committee meeting where the agency reviewed data on…
How ASCs ace the AAAHC accreditation survey
For an ambulatory surgery center (ASC), earning accreditation can be more than a mark of excellence. The Accreditation Association for Ambulatory Health Care (AAAHC) offers Medicare Deemed Status Accreditation, eliminating the need for separate surveys to certify compliance with the Conditions of Participation (CoPs) required by the Centers for Medicare…
Key tactics for OR emergency readiness: Supply audits, team drills
Editor’s Note: This page is a companion piece to the main article, Emergency preparedness: Identifying essential supplies for unplanned surgical events. While the main article outlines the principles of emergency readiness and supply preparation in the OR, the posts below offer a closer look at two key implementation areas: Supply…
Preoperative, postoperative GLP-1s improve weight loss in bariatric surgery patients
Editor's Note Research shows using GLP-1 receptor agonists both before and after bariatric surgery is associated with greater total weight loss than surgery alone, according to a July 13 article in MedPage Today. The article focuses on a retrospective analysis of 568 patients presented at ENDO 2025, the annual meeting…
Study: Stem cell strategy could eliminate kidney transplant patients’ need for immunosuppressants
Editor's Note A stem cell-based transplant method enabled most kidney recipients in a recent clinical trial to stop taking immunosuppressive drugs, according to a July 15 article in HealthDay. As detailed in the article, the approach was tested in a phase 3 multicenter, randomized controlled trial published in the American…
Free Daily News
- Large-scale studies link preoperative cognition to delirium risk, reveal its deadly toll after surgery
- Socioeconomic deprivation linked to lower fitness before surgery, UK study finds
- Perioperative medication decisions need individualized risk-benefit approach
- FDA: National IV saline shortage over after years of strained supply
- FDA announces Class 1 recall for Draeger breathing filters
- Hospital CEO departures surge, boards turn to interim leadership
- Study: Attire shapes patient trust, perceptions
- ASC drill success hinges on preparation, adaptability, clear roles
- Robotic surgery shows better outcomes in select emergency colorectal cases, poised for wider use
- 5 costly mistakes to avoid when building an ASC